Hwanin Pharmaceutical Reports 9.7 Billion KRW Operating Profit in 1Q, Down 19.5% YoY

[Asia Economy Reporter Kwon Jae-hee] Hwanin Pharmaceutical announced on the 28th that its sales revenue for the first quarter of 2022 reached 48.845 billion KRW, and operating profit was 9.716 billion KRW. Sales revenue increased by 8% compared to the same period last year, while operating profit decreased by 19.5%.